Sophie Rose will be attending the Milner Therapeutic Symposium hosted by the Milner Institute at the Corn Exchange Cambridge on Tuesday 25th June 2019. This symposium is an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma or biotech towards new treatments. Please email [...]
Metrion Biosciences will be attending the annual Ion Channel Modulation Symposium (ICMS) organised by Sophion Bioscience on Thursday 20th and Friday 21st June 2019. The meeting will take place at Clare College, Memorial Court, Cambridge. Metrion will be presenting a poster (title and presenter to be confirmed) and will also be attending the dinner on [...]
Metrion Biosciences' CSO Dr Marc Rogers will be attending World Preclinical Congress (WPC) in Boston from 17th to 20th June taking place at the Seaport World Trade Centre. Marc will be available to discuss Metrion's services and please email info@metrionbiosciences.com to make an appointment. Marc will also be co-presenting a poster alongside Dr Tom Mander [...]
Metrion Biosciences' Chief Scientific Officer, Dr Marc Rogers will be presenting at the Nanion User Meeting in Boston to be held at the Boston Marriott Long Wharf Hotel on 28th and 29th May 2019. Marc will be available during the event to discuss Metrion's range of ion channel drug discovery services. Please email info@metrionbiosciences.com to [...]
Metrion Biosciences' Business Manager Dr John Ridley and Senior Scientist Dr Edward Humphries will be attending the University of Copenhagen Ion Channel Forum on 23rd and 24th May 2019. Please contact info@metrionbiosciences.com to arrange a meeting with John and Edd at the event. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the [...]
Metrion Biosciences' Sales and Marketing Manager Dr Sophie Rose will be attending ELRIG Advances in Cell Based Screening hosted by The ELRIG Committee and AstraZeneca in Molndal, Sweden from Wednesday 22nd to Thursday 23rd May 2019. Sophie will be available to discuss Metrion's range of ion channel drug discovery services. Please email: info@metrionbiosciences.com if you [...]
Metrion Biosciences and AstraZeneca are co-hosting the 6th Cambridge Ion Channel Forum on Tuesday 9th April 2019 at the Milstein Building (Medimmune) at Granta Park, Great Abington. Registration is being co-ordinated by One Nucleus- please click here to request your place. The order of the day is as follows: Cambridge Ion Channel Forum – Tuesday [...]
Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer Cambridge, UK, 08 April 2019: Metrion Biosciences (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Dr Andrew Southan as Chief Executive Officer, with immediate effect. Dr Southan was previously the Company’s Chief Operating Officer. Dr Southan joined [...]
Metrion Biosciences' Sophie Rose and John Ridley will be attending ELRIG Research and Innovation 2019 to be held at Homerton College, Cambridge on Tuesday 2nd and Wednesday 3rd April. Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the [...]
Metrion Biosciences Closes Funding Round Includes investment from o2h Ventures Therapeutics Fund Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases Cambridge, UK, 01 April 2019: Metrion Biosciences Ltd (“Metrion”), the specialist ion channel contract research and drug discovery company, announced today that it has completed [...]
